Tryp Therapeutics to Present at the H.C. Wainwright Psychedelics Conference on December 6, 2021

SAN DIEGO, Dec. 3, 2021 /PRNewswire/ — Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (“Tryp or the “Company”), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, announced today that it will present at the 2nd Annual H.C….

No Comments

No comments yet.

Sorry, the comment form is closed at this time.